Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to drug pricing and access, and Medicare and Medicaid reimbursement
Source-reported fields
Filing overview
- Type
- 1st Quarter - Termination
- Posted
- Apr 16, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- RICCHETTI INCORPORATED
- Client
- EISAI, INC.
- Filing UUID
- 16a946c2-a490-46f3-906e-626831af6b1e
- Termination date
- Mar 31, 2025
Literal source text
Lobbying issues and bill citations
Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to drug pricing and access, and Medicare and Medicaid reimbursement; Issues related to pharmaceutical industry, generally
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.